U.S. FDA authorises Lucira's home test for flu and COVID-19
Feb 27 (Reuters) - Lucira Health LHDX.O said on Monday the U.S. Food and Drug Administration had granted emergency use authorization for its combination diagnostic test for COVID-19 and flu for over-the-counter use at home. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process